Steroid-resistant fulminant immune checkpoint inhibitor-associated myocarditis

28 August 2026 (11:21 - 11:33)

Organised by:

Slides

Sign in for access options

About the speaker

Doctor Ioannis Katsoularis

Umea University Hospital, Umea (Sweden)

4 More presentations in this session

Presentation thumbnail

Uncommon cause of multiple systemic embolism – cancer-related multivalve non infective endocarditis

Doctor C. Paraschiv (Bucharest, RO)

Presentation thumbnail

Cardio-oncology decision-making during trastuzumab-related cardiac dysfunction in high-risk HER2-positive breast cancer: a permissive cardiotoxicity approach

Doctor D. Ortega Gomez (Bogota, CO)

Presentation thumbnail

Breaking and fixing the heart - a case of trastuzumab-induced cancer therapy-related cardiac dysfunction

Doctor A. Fonseca Vazao (Leiria, PT)

Presentation thumbnail

Immune checkpoint inhibitor myocarditis and hypophysitis mimicking infective endocarditis

Doctor R. Van Lerberghe (Leuven, BE)

Access the full session

Session thumbnail

Cardio-oncology beyond cardiotoxicity

The Event

Event poster

ESC Congress 2026

28 August 2026 11:21 CET

You may be interested in

Congress Presentation

Immune checkpoint inhibitor-associated myocarditis: clinical characteristics, management, and outcomes from a tertiary cardio-oncology unit

21 June 2025

Congress Session

Inflammation in heart failure

19 May 2025

Webinar

How to manage cancer therapy-related cardiovascular toxicity. ESC 2022 Clinical Practice Guidelines - Webinar Series

19 September 2022

Congress Session

Cases with the European Heart Journal - Case Reports Editors

30 August 2026

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources